|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 31/498 | |||
| A61P 27/02 |
| (11) | Number of the document | 2305261 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10184295.3 |
| Date of filing the European patent application | 2005-04-26 | |
| (97) | Date of publication of the European application | 2011-04-06 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-26 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 836911 | 2004-04-30 | US |
| (72) |
Burke, James, US
Hughes, Patrick M., US
Zhang, Kai-Ming, US
Lin, Ton, US
Huang, Glenn T., US
Jackson, Brittany, US
Wheeler, Larry, US
Donn, Rosy S., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | METHODS OF MANUFACTURING INTRAOCULAR IMPLANTS OF ALPHA-2 ADRENERGIC RECEPTOR AGONISTS |
| METHODS OF MANUFACTURING INTRAOCULAR IMPLANTS OF ALPHA-2 ADRENERGIC RECEPTOR AGONISTS |